Tagraxofusp and Low-Intensity Chemotherapy for the Treatment of CD123 Positive Relapsed or Refractory Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
IGM Biosciences, Inc.
OHSU Knight Cancer Institute
University of California, San Diego
St. Jude Children's Research Hospital
National Cancer Institute (NCI)
H. Lee Moffitt Cancer Center and Research Institute